Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PGNY

PGNY - Progyny Inc Stock Price, Fair Value and News

$24.54+0.29 (+1.20%)
Market Closed

67/100

PGNY

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

67/100

PGNY

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$30.09

Target 3M

$26.35

Target 6M

$27.54

PGNY Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PGNY Price Action

Last 7 days

-3.6%

Last 30 days

-4.2%

Last 90 days

31.6%

Trailing 12 Months

4.0%

PGNY RSI Chart

PGNY Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PGNY Valuation

Market Cap

2.1B

Price/Earnings (Trailing)

37.4

Price/Sales (Trailing)

1.67

EV/EBITDA

19.88

Price/Free Cashflow

10.94

PGNY Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$30.09

Target 3M

$26.35

Target 6M

$27.54

PGNY Fundamentals

PGNY Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

9.32%

Rev. Growth (Qtr)

-5.87%

PGNY Earnings

Earnings (TTM)

56.6M

Earnings Growth (Yr)

33.04%

Earnings Growth (Qtr)

-18.98%

PGNY Profitability

EBT Margin

7.51%

Return on Equity

10.1%

Return on Assets

7.11%

Free Cashflow Yield

9.14%

PGNY Investor Care

Shares Dilution (1Y)

1.24%

Diluted EPS (TTM)

0.63

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.2B1.2B1.3B0
20241.1B1.1B1.1B1.2B
2023873.1M957.5M1.0B1.1B
2022550.7M617.1M700.1M786.9M
2021386.0M450.0M473.4M500.6M
2020263.5M271.9M309.7M344.9M
2019130.3M160.3M193.7M229.7M
201862.8M77.0M91.2M105.4M
201700048.6M
Get all data in R, Python etc through our Historical Stock Data APIs

About Progyny Inc

PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
 CEO
 WEBSITEprogyny.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES393

Progyny Inc Frequently Asked Questions

PGNY is the stock ticker symbol of Progyny Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Progyny Inc is 2.12 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check PGNY's fair value in chart for subscribers.

The fair value guage provides a quick view whether PGNY is over valued or under valued. Whether Progyny Inc is cheap or expensive depends on the assumptions which impact Progyny Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PGNY.

As of Wed Jan 28 2026, PGNY's PE ratio (Price to Earnings) is 37.4 and Price to Sales (PS) ratio is 1.67. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PGNY PE ratio will change depending on the future growth rate expectations of investors.